XWELL Inc. (XWEL) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.003x

Based on the latest financial reports, XWELL Inc. (XWEL) has a cash flow conversion efficiency ratio of 0.003x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-42.00K) by net assets ($-12.58 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See XWELL Inc. balance sheet quality to measure how much of total assets are equity-financed.

XWELL Inc. - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how XWELL Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check XWEL cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

XWELL Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of XWELL Inc. ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Lykos Metals Ltd
AU:LYK
-0.312x
Core AI Holdings
NASDAQ:CHAI
N/A
Image Systems AB
ST:IS
-0.090x
Infobird Co Ltd
NASDAQ:IFBD
-0.090x
Versus Systems Inc
NASDAQ:VS
0.120x
Nakoda Group of Industries Limited
NSE:NGIL
-0.035x
Argentina Lithium & Energy Corp
V:LIT
-0.020x
Conduit Holdings Ltd
LSE:CRE
0.264x

Annual Cash Flow Conversion Efficiency for XWELL Inc. (2008–2025)

The table below shows the annual cash flow conversion efficiency of XWELL Inc. from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see XWELL Inc. (XWEL) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $-12.58 Million $-8.71 Million 0.693x +148.72%
2024-12-31 $7.74 Million $-11.01 Million -1.421x -85.45%
2023-12-31 $20.97 Million $-16.07 Million -0.766x -51.94%
2022-12-31 $47.95 Million $-24.19 Million -0.504x -422.29%
2021-12-31 $99.94 Million $15.64 Million 0.157x +150.30%
2020-12-31 $80.37 Million $-25.01 Million -0.311x -798.43%
2019-12-31 $-2.54 Million $-113.00K 0.045x +108.91%
2018-12-31 $13.13 Million $-6.57 Million -0.500x -88.25%
2017-12-31 $45.84 Million $-12.17 Million -0.266x -101.86%
2016-12-31 $64.17 Million $-8.44 Million -0.132x -107.30%
2015-12-31 $40.52 Million $-2.57 Million -0.063x +93.03%
2014-12-31 $31.18 Million $-28.38 Million -0.910x -343.33%
2013-12-31 $114.28 Million $-23.46 Million -0.205x -110.51%
2012-12-31 $148.33 Million $-14.47 Million -0.098x -102.11%
2011-12-31 $-1.17 Million $-5.38 Million 4.618x -82.65%
2010-12-31 $-239.00K $-6.36 Million 26.615x +8887.66%
2009-12-31 $-16.38 Million $-4.85 Million 0.296x -55.48%
2008-12-31 $-10.97 Million $-7.30 Million 0.665x --

About XWELL Inc.

NASDAQ:XWEL USA Diagnostics & Research
Market Cap
$7.77 Million
Market Cap Rank
#27639 Global
#5625 in USA
Share Price
$0.98
Change (1 day)
-10.09%
52-Week Range
$0.29 - $1.70
All Time High
$4680.00
About

XWELL, Inc. provides health and wellness services to travelers in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment provides traveler's spa services, including massage, and nail and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests to airport empl… Read more